Ovidrel and Lupron drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ovidrel (choriogonadotropin alfa) and Lupron (leuprolide acetate). Common drug interactions include headache among females.
The phase IV clinical study analyzes what interactions people have when they take Ovidrel and Lupron. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.
What is Ovidrel?
Ovidrel has active ingredients of choriogonadotropin alfa. eHealthMe is studying from 532 Ovidrel users. Check the latest studies of Ovidrel.
What is Lupron?
Lupron has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 42,122 Lupron users. Check the latest studies of Lupron.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
17 people who take Ovidrel and Lupron together, and have interactions are studied.

What are the common drug interactions of Ovidrel and Lupron, by gender? *:
female:
- Headache (pain in head)
- Chest pain
- Nausea (feeling of having an urge to vomit)
- Ovarian hyperstimulation syndrome (excess egg stimulation from ovary due to medicine)
- Pain
- Heart rate increased
- Night sweats (sweating in night)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Abdominal distension
- Anal atresia (anus is either not present or it is in the wrong place)
male:
n/a
What are the common drug interactions of Ovidrel and Lupron, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Chest pain
- Abortion spontaneous (naturally occurring miscarriage)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Diarrhoea
- Drug exposure during pregnancy
- Dyspnoea (difficult or laboured respiration)
- Injury
- Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
- Ovarian enlargement
- Ovarian hyperstimulation syndrome (excess egg stimulation from ovary due to medicine)
40-49:
n/a
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Infertility Female: 6 people, 35.29%
- Ovulation Induction: 3 people, 17.65%
- Infertility: 2 people, 11.76%
* Approximation only. Some reports may have incomplete information.
Do you take Ovidrel and Lupron?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ovidrel and Lupron:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ovidrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lupron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ovidrel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lupron and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on choriogonadotropin alfa and leuprolide acetate (the active ingredients of Ovidrel and Lupron, respectively), and Ovidrel and Lupron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lenvima cause Intestinal Obstruction? - now
- Could Glimepiride cause International Normalised Ratio Decreased? - 12 seconds ago
- Fabry'S Disease and Rashes - 23 seconds ago
- Drug interactions of Prevpac and Prednisone - 27 seconds ago
- Could Anafranil cause Dehydration? - 28 seconds ago
- Could Spironolactone cause Stenotrophomonas Infection? - 40 seconds ago
- Could Adempas cause Flatulence? - 44 seconds ago
- Could Asa cause Facet Joint Syndrome? - 46 seconds ago
- Latuda and Seizure Control for Boys aged 10-19 - 48 seconds ago
- Latuda and Seizure for Boys aged 10-19 - 48 seconds ago